Company Doa Pharma Consulting Srl with Fiscal Code 37099630
recorded a turnover of 2024 of
29.391,
with a net profit of
1.395
and having an average number of employees of
1.
The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Doa Pharma Consulting Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
17.315
7.052
10.826
1.984
5.502
16.262
41.755
29.391
Total Income - EUR
-
-
17.537
7.167
10.957
2.065
5.544
16.247
41.755
31.262
Total Expenses - EUR
-
-
2.356
3.779
2.474
1.170
2.649
45.277
37.010
28.930
Gross Profit/Loss - EUR
-
-
15.181
3.387
8.482
895
2.895
-29.029
4.744
2.332
Net Profit/Loss - EUR
-
-
14.655
3.172
8.154
835
2.762
-29.256
4.327
1.395
Employees
-
-
0
0
0
0
0
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -29.2%, from 41.755 euro in the year 2023, to 29.391 euro in 2024.
The Net Profit decreased by -2.908 euro, from 4.327 euro in 2023, to 1.395 in the last year.
Check the financial reports for the company - Doa Pharma Consulting Srl
Financial Rating - DOA PHARMA CONSULTING SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Doa Pharma Consulting Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Doa Pharma Consulting Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Doa Pharma Consulting Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Doa Pharma Consulting Srl - CUI 37099630
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
-
15
10
7
2
0
47.114
39.782
33.491
Current Assets
-
-
14.705
3.232
8.343
1.038
12.817
46.142
78.136
110.471
Inventories
-
-
0
0
0
0
5.483
33.879
67.694
103.577
Receivables
-
-
492
0
0
0
1.101
9.581
6.178
4.378
Cash
-
-
14.212
3.232
8.343
1.038
6.233
2.681
4.265
2.516
Shareholders Funds
-
-
14.698
3.224
8.204
885
3.627
-25.618
-21.214
-19.700
Social Capital
-
-
44
43
42
41
40
41
40
40
Debts
-
-
73
18
146
155
9.287
121.254
140.724
165.027
Income in Advance
-
-
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
110.471 euro in 2024 which includes Inventories of
103.577 euro, Receivables of
4.378 euro and cash availability of
2.516 euro.
The company's Equity was valued at
-19.700 euro, while total Liabilities amounted to
165.027 euro.
Equity increased by 1.395 euro, from -21.214 euro in 2023, to -19.700 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Doa Pharma Consulting Srl